Article Details
Retrieved on: 2024-10-01 20:07:10
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Luxa Biotechnology's development of RPESC therapy for dry age-related macular degeneration, a type of regenerative medicine. The key concept and tags highlight the use of stem cells, specifically RPESC, in treating eye diseases like macular degeneration.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here